These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26363485)

  • 1. Are we stopping preterm birth trials too early?
    Byrne R; Mol B
    Am J Obstet Gynecol; 2016 Jan; 214(1):134-5. PubMed ID: 26363485
    [No Abstract]   [Full Text] [Related]  

  • 2. The choice of progestogen for the prevention of preterm birth in women with singleton pregnancy and prior preterm birth.
    Society for Maternal-Fetal Medicine (SMFM) Publications Committee
    Am J Obstet Gynecol; 2017 Mar; 216(3):B11-B13. PubMed ID: 28126367
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply.
    Rozenberg P; Winer N
    Am J Obstet Gynecol; 2016 Jan; 214(1):135. PubMed ID: 26348377
    [No Abstract]   [Full Text] [Related]  

  • 4. Reducing preterm births.
    Reprod Biomed Online; 2007 May; 14(5):663. PubMed ID: 17509212
    [No Abstract]   [Full Text] [Related]  

  • 5. 17 alpha-hydroxyprogesterone caproate does not prolong pregnancy or reduce the rate of preterm birth in women at high risk for preterm delivery and a short cervix: a randomized controlled trial.
    Winer N; Bretelle F; Senat MV; Bohec C; Deruelle P; Perrotin F; Connan L; Vayssière C; Langer B; Capelle M; Azimi S; Porcher R; Rozenberg P;
    Am J Obstet Gynecol; 2015 Apr; 212(4):485.e1-485.e10. PubMed ID: 25448515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17 OHPC for prevention of preterm birth in twins: back to the drawing board?
    Durnwald CP
    Am J Obstet Gynecol; 2013 Mar; 208(3):167-8. PubMed ID: 23433323
    [No Abstract]   [Full Text] [Related]  

  • 7. Reducing Barriers to 17-Hydroxprogestrone Caproate (17P) Injections to Prevent Recurrent Preterm Birth in Mississippi.
    Bofill JA; Collier CH; Pearson M; Shwayder JM; Morrison JC
    J Miss State Med Assoc; 2016 Nov; 57(11):350-351. PubMed ID: 30281234
    [No Abstract]   [Full Text] [Related]  

  • 8. What agent should be used to prevent recurrent preterm birth: 17-P or natural progesterone?
    Hall NR
    Obstet Gynecol Clin North Am; 2011 Jun; 38(2):235-46, ix-x. PubMed ID: 21575799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reply: To PMID 23433324.
    Senat MV; Rozenberg P
    Am J Obstet Gynecol; 2013 Sep; 209(3):283-4. PubMed ID: 23628261
    [No Abstract]   [Full Text] [Related]  

  • 10. Gestiva for preventing prematurity: a new view of an old therapy.
    Cypher R
    Nurs Womens Health; 2007 Jun; 11(3):322-5. PubMed ID: 17883780
    [No Abstract]   [Full Text] [Related]  

  • 11. 17-alpha-hydroprogesterone caproate and cervical changes.
    Facchinetti F
    Am J Obstet Gynecol; 2010 Sep; 203(3):e9; author reply e10. PubMed ID: 20537309
    [No Abstract]   [Full Text] [Related]  

  • 12. Mortality related to 17-OHPC exposure is an important safety outcome.
    O'Brien JM
    Am J Obstet Gynecol; 2013 Sep; 209(3):282-3. PubMed ID: 23628265
    [No Abstract]   [Full Text] [Related]  

  • 13. 17-α hydroxyprogesterone caproate for the prevention of preterm birth.
    Gupta S; Roman AS
    Womens Health (Lond); 2012 Jan; 8(1):21-30. PubMed ID: 22171770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is 17α-hydroxyprogesterone caproate contraindicated in twin gestations?
    Romero R; Conde-Agudelo A
    BJOG; 2015 Jan; 122(1):6-7. PubMed ID: 25280114
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of hydroxyprogesterone caproate to prevent preterm labour in uterine didelphys: a case report.
    Ng KS; Ng BK; Lim PS; Shafiee MN; Abdul Karim AK; Omar MH
    Horm Mol Biol Clin Investig; 2016 Sep; 27(3):89-91. PubMed ID: 26684353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17-alpha hydroxyprogesterone caproate for preterm birth prevention: Where have we been, how did we get here, and where are we going?
    Manuck TA
    Semin Perinatol; 2017 Dec; 41(8):461-467. PubMed ID: 28947068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial.
    Combs CA; Garite T; Maurel K; Das A; Porto M;
    Am J Obstet Gynecol; 2011 Mar; 204(3):221.e1-8. PubMed ID: 21376161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. There is still insufficient data to recommend screening twin pregnancies with transvaginal ultrasound cervical length, but this might change soon!
    Gimovsky A; Berghella V
    BJOG; 2015 Jan; 122(1):38. PubMed ID: 25145404
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
    O'Brien JM; Lewis DF
    Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of 17-α-hydroxyprogesterone caproate on preterm birth prevention in women with history-indicated cerclage.
    Mackeen AD; Rafael TJ; Zavodnick J; Berghella V
    Am J Perinatol; 2013 Oct; 30(9):755-8. PubMed ID: 23341330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.